Pecoits-Filho R, Okpechi IG, Donner JA, et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int Suppl (2011). 2020;10(1):e3–9.
Article
Google Scholar
Bello AK, Levin A, Tonelli M, et al. Assessment of Global Kidney Health Care Status. JAMA. 2017;317(18):1864–81.
Article
PubMed
PubMed Central
Google Scholar
Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367:l5873.
Article
PubMed
Google Scholar
Htay H, Bello AK, Levin A, et al. Hemodialysis Use and Practice Patterns: An International Survey Study. Am J Kidney Dis. 2021;77(3):326–35.
Article
PubMed
Google Scholar
Tsiagka D, Georgianos PI, Pikilidou MI, et al. Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis. Int Urol Nephrol. 2022;54(9):2327–34.
Kovesdy CP, Matsushita K, Sang Y, et al. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. Eur Heart J. 2018;39:1535–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bem D, Sugrue D, Wilding B, et al. The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review. Ren Fail. 2021;43(1):241–54.
Article
PubMed
PubMed Central
Google Scholar
Lehnhardt A, Kemper M. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2011;26:377–84.
Article
PubMed
Google Scholar
Spodick DH. Effects of severe hyperkalemia. Am Heart Hosp J. 2008;6:68.
Article
PubMed
Google Scholar
Georgianos PI, Sarafidis PA, Sinha AD, Agarwal R. Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals? Am J Nephrol. 2015;41(4–5):400–8.
Article
PubMed
Google Scholar
Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB. Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study. Am J Nephrol. 2016;44(3):179–86.
Article
CAS
PubMed
Google Scholar
Luo J, Brunelli SM, Jensen DE, Yang A. Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol. 2016;11(1):90–100.
Article
CAS
PubMed
Google Scholar
Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21.
Article
CAS
PubMed
Google Scholar
Karaboyas A, Zee J, Brunelli SM, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017;69(2):266–77.
Article
CAS
PubMed
Google Scholar
Nakhoul GN, Huang H, Arrigain S, et al. Serum potassium, end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol. 2015;41(6):456–63.
Article
CAS
PubMed
Google Scholar
Kovesdy CP. Management of hyperkalemia in chronic kidney disease. Nat Rev Nephrol. 2014;10(11):653–62.
Article
CAS
PubMed
Google Scholar
Bai ZH, Guo XQ, Dong R, et al. A Nomogram to Predict the 28-day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy. Am J Med Sci. 2021;361(5):607–15.
Article
PubMed
Google Scholar
Yang S, Su T, Huang L, et al. A novel risk-predicted nomogram for sepsis associated-acute kidney injury among critically ill patients. BMC Nephrol. 2021;22(1):173.
Article
PubMed
PubMed Central
Google Scholar
Zhou Y, He Y, Yang H, et al. Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China. PLoS One. 2020;15(5):e0233328.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Tao L, Gao Z, et al. Development and validation of a prediction model for early identification of critically ill elderly COVID-19 patients. Aging (Albany NY). 2020;12(19):18822–32.
Article
CAS
Google Scholar
Jiang X, Su Z, Wang Y, et al. Prognostic nomogram for acute pancreatitis patients: An analysis of publicly electronic healthcare records in intensive care unit. J Crit Care. 2019;50:213–20.
Article
PubMed
Google Scholar
Johnson ES, Weinstein JR, Thorp ML, et al. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf. 2010;19(3):266–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma A, Alvarez PJ, Woods SD, Dai D. A model to predict risk of hyperkalemia in patients with chronic kidney disease using a large administrative claims database. Clinicoecon Outcomes Res. 2020;12:657–67.
Article
PubMed
PubMed Central
Google Scholar
Davies SJ, Zhao J, Morgenstern H, et al. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS. Kidney Int Rep. 2020;6(2):313–24.
Article
PubMed
PubMed Central
Google Scholar
Agiro A, Duling I, Eudicone J, et al. The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study. Hemodial Int. 2022;26(3):397–407.
Article
PubMed
PubMed Central
Google Scholar
Rossignol P, Lamiral Z, Frimat L, et al. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey. Nephrol Dial Transplant. 2017;32(12):2112–8.
Article
CAS
PubMed
Google Scholar
Ramos CI, González-Ortiz A, Espinosa-Cuevas A, Avesani CM, Carrero JJ, Cuppari L. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2021;36(11):2049–57.
Article
CAS
PubMed
Google Scholar
St-Jules DE, Marinaro M, Goldfarb DS, Byham-Gray LD, Wilund KR. Managing hyperkalemia: another benefit of exercise in people with chronic kidney disease? J Ren Nutr. 2020;30(5):380–3.
Article
CAS
PubMed
Google Scholar
Wouda RD, Vogt L, Hoorn EJ. Personalizing potassium management in patients on haemodialysis. Nephrol Dial Transplant. 2021;36(1):13–8.
Article
PubMed
Google Scholar
Shibata S, Uchida S. Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management. Ther Apher Dial. 2022;26(1):3–14.
Article
PubMed
Google Scholar
Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis. 2010;56:338–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
St-Jules DE, Goldfarb DS, Sevick MA. Nutrient non-equivalence: does restricting high-potassium plant foods help to prevent hyperkalemia in hemodialysis patients? J Ren Nutr. 2016;26:282–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gupta AA, Self M, Mueller M, Wardi G, Tainter C. Dispelling myths and misconceptions about the treatment of acute hyperkalemia. Am J Emerg Med. 2022;52:85–91.
Article
PubMed
Google Scholar
Lee S, Sirich TL, Meyer TW. Improving Clearance for Renal Replacement Therapy. Kidney360. 2021;2(7):1188–95.
Article
PubMed
PubMed Central
Google Scholar
Clase CM, Carrero J-J, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disese: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(1):42–61.
Article
CAS
PubMed
Google Scholar
Palmer BF, Clegg DJ. Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity. Mayo Clin Proc. 2016;91(4):496–508.
Article
PubMed
Google Scholar
Karaboyas A, Xu H, Morgenstern H, et al. DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients. Kidney Int. 2018;94(3):589–98.
Article
CAS
PubMed
Google Scholar